↓ Skip to main content

Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

Overview of attention for article published in BMC Cancer, May 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

blogs
1 blog
video
2 YouTube creators

Citations

dimensions_citation
101 Dimensions

Readers on

mendeley
84 Mendeley
connotea
1 Connotea